Five Beaten-Up Biotech Stocks Saw Big Share Purchases

Biotech stocks have taken some lumps this year, and some have seen some large stock purchases made by big shareholders.

Shares of cancer-therapy developers Kymera Therapeutics (ticker: KYMR), Cullinan Oncology (CGEM), and Repare Therapeutics (RPTX) are down 77%, 22%, and 35%, respectively, so far this year.

Kymera’s first-quarter report and…

 » Read More  » Read More

Tags: No tags

Comments are closed.